NCT01121198View on ClinicalTrials.gov

A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Healthy VolunteerPharmacokinetics of ASP1941
Interventions
DRUG

ASP1941

oral

DRUG

placebo

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY